Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation
Bioconjugate Chemistry · 19.07.2023 · 34 (7) · 1316-1326
DOI: 10.1021/acs.bioconjchem.3c00239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 18.06.2023. Verfasst von Xiangjie Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Chemical Biology, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, and Department of Chemica…. Hauptthemen laut MEDLINE: Inflammation, Macrophages. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Youth Innovation Foundation of Xiamen, Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammation-related diseases affect large populations of people in the world and cause substantial healthcare burdens, which results in significant costs in time, material, and labor. Preventing or relieving uncontrolled inflammation is critical for the treatment of these diseases. Herein, we report a new strategy for alleviating inflammation by macrophage reprogramming via targeted reactive oxygen species (ROS) scavenging and cyclooxygenase-2 (COX-2) downregulation. As a proof of concept, we synthesize a multifunctional compound named MCI containing a mannose-based macrophage targeting moiety, an indomethacin (IMC)-based segment for inhibiting COX-2, and a caffeic acid (CAF)-based section for ROS clearance. As revealed by a series of in vitro experiments, MCI could significantly attenuate the expression of COX-2 and the level of ROS, leading to M1 to M2 macrophage reprogramming, as evidenced by the reduction and the elevation in the levels of pro-inflammatory M1 markers and anti-inflammatory M2 markers, respectively. Furthermore, in vivo experiments show MCI's promising therapeutic effects on rheumatoid arthritis (RA). Our work illustrates the success of targeted macrophage reprogramming for inflammation alleviation, which sheds light on the development of new anti-inflammatory drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Chemical Biology, The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, and Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen Unive…
ORCID-Profile: Hongyu Lin, Jinhao Gao
Förderung
- Youth Innovation Foundation of Xiamen
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Luo, X., Xiong, H., Jiang, Y., Fan, Y., Zuo, C., Chen, D., Chen, L., Lin, H., & Gao, J. (2023). Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation. Bioconjugate Chemistry, 34(7), 1316-1326. https://doi.org/10.1021/acs.bioconjchem.3c00239
Vancouver
Luo X, Xiong H, Jiang Y, Fan Y, Zuo C, Chen D, et al. Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation. Bioconjugate Chemistry. 2023;34(7):1316-1326. doi:10.1021/acs.bioconjchem.3c00239
BibTeX
@article{Luo2023,
author = {Luo, Xiangjie and Xiong, Hui and Jiang, Yuhang and Fan, Yifan and Zuo, Cuicui and Chen, Dongxia and Chen, Limin and Lin, Hongyu and Gao, Jinhao},
title = {Macrophage Reprogramming via Targeted ROS Scavenging and COX-2 Downregulation for Alleviating Inflammation},
journal = {Bioconjugate Chemistry},
year = {2023},
volume = {34},
number = {7},
pages = {1316--1326},
doi = {10.1021/acs.bioconjchem.3c00239}
}
EUVIMED